VYGR — Voyager Therapeutics Share News
0.000.00%
Last trade - 00:00- $107.22m
- -$9.12m
- $40.37m
Voyager Therapeutics as Q1 results blow past estimates
Voyager Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Voyager Therapeutics Reports First Quarter Earnings Per Share $2.94
Brief: Voyager Therapeutics Reports Q1 2023 Financial And Operating Results
Brief: Voyager Therapeutics Announces Appointment Of George Scangos, Ph.D., To Board Of Directors
Voyager Therapeutics Inc expected to post earnings of $1.12 a share - Earnings Preview
Voyager Therapeutics Inc expected to post earnings of $1.12 a share - Earnings Preview
Brief: Voyager Therapeutics Says Currently Maintains Operating Account, Restricted Cash Deposit At Svb
Voyager Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Voyager Therapeutics Inc expected to post a loss of 55 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Goldman Sachs, Natural gas, Chipmakers
U.S. STOCKS ON THE MOVE-Abercrombie & Fitch, Lululemon Athletica, Oracle
U.S. STOCKS ON THE MOVE-Amazon.com, Paya Holdings, Bed Bath & Beyond
Voyager Therapeutics jumps on deal to develop gene therapies with Neurocrine
Brief: Neurocrine Biosciences And Voyager Therapeutics Collaborates For Neurological Disease Treatments
Brief: Voyager Therapeutics Inc Files For Mixed Shelf Of Up To $300 Mln
Voyager Therapeutics Inc reports results for the quarter ended in September - Earnings Summary
Brief: Voyager Therapeutics Reports Third Quarter Financial And Operating Results
Voyager Therapeutics Inc expected to post a loss of 32 cents a share - Earnings Preview